Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NC/Gastonia
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Gastonia, NC

Studies commonly pay $75 to $4,500 per completed study

659 clinical trials are currently recruiting participants within 30 miles of Gastonia. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

659studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Gastonia right now

Top 25 of 659 recruiting studies, sorted by proximity — each links to its official registry page

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
Carolinas Medical Center/Levine Children's Hospital (Adults and Pediatrics) — Charlotte, North Carolina (19.4 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Novant Health Presbyterian Medical Center — Charlotte, North Carolina (19.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
Carolina BioOncology Institute — Huntersville, North Carolina (22.3 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06040541)

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment Phase 4 Interventional 60 participants sought
Research Site — Charlotte, North Carolina (19.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06651970)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Charlotte, North Carolina (19.4 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Triple Negative Breast Cancer, HER2-negative Breast Cancer Phase 1 Interventional 96 participants sought
Dren Investigational Site — Huntersville, North Carolina (22.3 mi) · Sponsor: Dren Bio
See eligibility & contact on ClinicalTrials.gov (NCT06999187)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
Atrium Health — Charlotte, North Carolina (19.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196748)

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Renal Cell Carcinoma Phase 3 Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (19.4 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07227402)

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

Severe Asthma Phase 2 Interventional 512 participants sought
Research site — Charlotte, North Carolina (19.4 mi) · Sponsor: Kinaset Therapeutics Inc
See eligibility & contact on ClinicalTrials.gov (NCT07532265)

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought
Clinical Trial Site — Charlotte, North Carolina (19.4 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04202341)

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Pediatric Cancer Phase 2 Interventional 64 participants sought
Levine Cancer Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT04948619)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,500 participants sought
Gibbs Cancer Center-Gaffney — Gaffney, South Carolina (29.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1, Narcolepsy Type 2 Phase 2, Phase 3 Interventional 786 participants sought
Alkermes Investigational Site — Denver, North Carolina (21.4 mi) · Sponsor: Alkermes, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06767683)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
Novant Health Cancer Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Charlotte, North Carolina (19.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Levine Cancer Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Advanced Solid Tumor Phase 1, Phase 2 Interventional 499 participants sought
Clinical Trial Site — Huntersville, North Carolina (22.3 mi) · Sponsor: Arvinas Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07749586)

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

Post Operative Surgical Site Infection Phase 3 Interventional 600 participants sought
Atrium Health Carolinas Medical Center — Charlotte, North Carolina (19.4 mi) · Sponsor: Major Extremity Trauma Research Consortium
See eligibility & contact on ClinicalTrials.gov (NCT04678154)

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL) Phase 2 Interventional 75 participants sought
Novant Health Presbyterian Medical Center /ID# 230201 — Charlotte, North Carolina (19.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04895436)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05382338)

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10318, Charlotte, NC — Charlotte, North Carolina (19.4 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06024746)

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Colitis, Ulcerative N/A Observational 300 participants sought
OnSite Clinical Solutions, LLC — Charlotte, North Carolina (19.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06398626)
Actively enrolling

Studies you may be able to join near Gastonia

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Gastonia

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Research of Gastonia

1010 X Ray Dr # A, Gastonia, NC 28054
(704) 675-7144

Atrium Health Levine Cancer Institute

★ 4.7 (149 reviews)
2610 Aberdeen Blvd, Gastonia, NC 28054
(980) 442-4500
"Friendly staff. I was taken care of completely."
— Jason Heinzen, 5★

Rose Research Center

★ 4.9
8401 Medical Plaza Dr #275, Charlotte, NC 28262
(704) 350-2999
"I had an excellent experience I am definitely team Mary Beth and team rejoice definitely five stars for the ladies"
— Griselda Crawford, 5★

DelRicht Research | Charlotte Clinical Trials

★ 4.8
6719 Fairview Rd Ste A, Charlotte, NC 28210
(704) 644-8469
"The team members are kind and considerate. They will answer questions and provide you with feedback you can share with your primary provider. Super P…"
— Kenya Davis, 5★

Queen City Clinical Research, PLLC

330 Billingsley Rd Ste 206?, Charlotte, NC 28211
(704) 405-3150

Catawba Research, LLC

★ 5.0
5200 77 Center Dr #160, Charlotte, NC 28217
(980) 242-3980

New Hope Clinical Research, Inc.

★ 4.2
3101 Latrobe Dr, Charlotte, NC 28211
(980) 209-9784
"They called to screen me and I’m not even depressed. Just lied because I need the money. I’m sure they haven’t called a bunch of others like they cal…"
— Pluto Enterprises LLC, 3★

Partners Health Management

★ 2.4 (10 reviews)
901 S New Hope Rd, Gastonia, NC 28054
(888) 235-4673
"Being forced with no forewarning at all to switch and not told through phone, email or anything.They say I have to switch June 1st,<br>I love where I…"
— Wenlady, 1★

Carolinas Research Center

★ 5.0
1805 Milton Rd # B, Charlotte, NC 28215
(704) 595-7887

Clinical trials in Gastonia: what's recruiting

The Gastonia area currently has 659 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Gastonia, the most active research areas are:

  • Cancer & Oncology15 studies
  • Immune & Skin2 studies
  • Liver & Kidney1 studies
  • Lungs & Breathing1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Gastonia, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Gastonia

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Gastonia participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Gastonia pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Gastonia safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Gastonia, NC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Gastonia?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Gastonia typically complete one or two studies per year.

Paid clinical trials near Gastonia

Other metros within reach

Rock Hill, SC601 Charlotte, NC663 Hickory, NC96 Concord, NC640 Spartanburg, SC366 Mauldin, SC380 Columbia, SC192 Greenville, SC382

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Gastonia Chronic Kidney Disease (HealthMatch) in Gastonia Bladder Issues Due To Spinal Cord Injury in Gastonia All conditions

More of NC

Durham1,695 Cary1,695 Raleigh1,686 Burlington745 Charlotte663 Concord640 Winston-Salem588 High Point587 Greensboro586 Asheville126 Fayetteville123

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts